TLRY | tickerfilter.com

Fundamental analysis

15%

Profitability 0%

Dept financing 25%

Liquidity 0%

Performance 30%

Performance

5 Days

-22.95%

1 Month

-29.86%

3 Months

-42.78%

6 Months

-42.78%

1 Year

-42.78%

2 Year

-42.78%

Key data

Stock price

$0.46

P/E Ratio

N/A

DAY RANGE

$0.45 - $0.58

EPS

N/A

52 WEEK RANGE

$0.45 - $0.84

52 WEEK CHANGE

-$42.78

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-08-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$23,286,203

AVERAGE 30 VOLUME

$31,437,755

Company detail

CEO: Irwin D. Simon
Region: US
Website: tilray.com
Employees: 1,700
IPO year: 2018

Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.

TLRY - Tilray Brands, Inc.